pharmacologyacetylcholinecytokinesaquaporinsneuroimagingneuroinflammationanimal models of diseasesyringomyeliaCNS injuryCSF physiologyneuroscience
Doctor Woodcock joined Macquarie Neurosurgery in 2011 as a post-doctoral research fellow in the Australian School of Advanced Medicine. His primary research focus is on improving our understanding of cerebrospinal fluid physiology. By elucidating the pathways and mechanisms by which fluid flows through the central nervous system he hopes to gain insight into various central nervous system pathologies. His work has implications for the development of treatments for diseases including syringomyelia, hydrocephalus, and Alzheimer’s disease. He was awarded a Macquarie Research Development Grant in 2012 to develop a technique for quantifying fluid flow in the spinal cord.
Doctor Woodcock was awarded his Ph.D. in 2009 from the University of Kentucky for his work on the modulation of nicotinic receptors following traumatic brain injury. He then moved to Australia, where he studied the role of cytokines in brain injury at the National Trauma Research Center in Melbourne.
The scavenging chemokine receptor ACKR2 has a significant impact on acute mortality rate and early lesion development after traumatic brain injury